Brief: CanSino's COVID Vaccine Gets Approval For Emergency Use
Dec 3 (Reuters) - CanSino Biologics Inc
6185.HK 688185.SS :
* SAYS ITS INHALED COVID XBB.1.5 VARIANT VACCINE GETS
APPROVED BY
CHINESE AUTHORITY FOR EMERGENCY USE
Source text
Further company coverage: 6185.HK
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Cansino Biologics
See all newsBrief: CanSino Biologics Says China's NMPA Granted Priority Review Status To NDA For TD5CP Adolescent, Adult
Brief: CanSino Biologics Reports Widened Net Loss For Q1
Brief: CanSino Biologics Says 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Prelim 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Expects To Have Returned to Net Profit In 2025